Transmembrane Protein 106B (TMEM106B)
TMEM106B expression in frontal cortex. In silico analysis revealed TMEM106B expression in lymphoblastoid cell lines.TMEM106B gene maps to chromosome 7p21.3.For a discussion of a possible association between variation in the TMEM106B gene and susceptibility to frontotemporal lobar degeneration with TDP43 inclusions.
TMEM106B expression compared to controls, and this expression correlated with presence of the T risk allele; these results were found in both GRN-positive and GRN-negative individuals. The results were compatible with a model in which mutations in GRN may act upstream of TMEM106B expression in increasing the risk for FTLD-TDP.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Transmembrane Protein 106B (TMEM106B) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Transmembrane Protein 106B (TMEM106B) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Transmembrane Protein 106B (TMEM106B) Polyclonal Antibody Customized Service Offer
Assay Kits SEN905Hu ELISA Kit for Transmembrane Protein 106B (TMEM106B) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Transmembrane Protein 106B (TMEM106B) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Transmembrane Protein 106B (TMEM106B) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Transmembrane Protein 106B (TMEM106B) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Transmembrane Protein 106B (TMEM106B) CLIA Kit Customized Service Offer
n/a ELISA Kit for Transmembrane Protein 106B (TMEM106B) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Transmembrane Protein 106B (TMEM106B) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Transmembrane Protein 106B (TMEM106B) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Transmembrane Protein 106B (TMEM106B) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Transmembrane Protein 106B (TMEM106B) CLIA Kit Customized Service Offer
n/a ELISA Kit for Transmembrane Protein 106B (TMEM106B) ELISA Kit Customized Service Offer
  1. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  2. "Human chromosome 7: DNA sequence and biology." Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract]
  3. "The DNA sequence of human chromosome 7." Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  6. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
  7. "Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions." Nat. Genet. 42:234-239(2010) [PubMed] [Europe PMC] [Abstract]
  8. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  9. "TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers." Neurology 76:467-474(2011) [PubMed] [Europe PMC] [Abstract]
  10. "Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration."J. Biol. Chem. 287:19355-19365(2012) [PubMed] [Europe PMC] [Abstract]
  11. "TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways."J. Neurosci. 32:11213-11227(2012) [PubMed] [Europe PMC] [Abstract]
  12. "The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function."Hum. Mol. Genet. 22:685-695(2013) [PubMed] [Europe PMC] [Abstract]
  13. "TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia."J. Neurochem. 126:781-791(2013) [PubMed] [Europe PMC] [Abstract]
  14. "TMEM106B: a strong FTLD disease modifier."Acta Neuropathol. 127:419-422(2014) [PubMed] [Europe PMC] [Abstract]
  15. "TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions." Acta Neuropathol. 127:407-418(2014) [PubMed] [Europe PMC] [Abstract]
  16. "TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia." Acta Neuropathol. 127:397-406(2014) [PubMed] [Europe PMC] [Abstract]
  17. "The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes."EMBO J. 33:450-467(2014) [PubMed] [Europe PMC] [Abstract]